Ulrike Künzel

Ulrike Künzel is an Associate Principal Scientist in the Functional Genomics team at AstraZeneca and co-leads the MRC-AstraZeneca University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL). In this role, Ulrike manages CRISPR screening initiatives that bridge academia and industry, aiming to uncover novel biological insights and identify drug targets for chronic diseases. Ulrike gained expertise in the development of cellular assays for screening and performing (whole genome) CRISPR screens for target identification and validation across AstraZeneca's portfolio. Before joining AstraZeneca in 2019, Ulrike worked as a Research Associate at Evotec in Hamburg, Germany where she developed a workflow for generating CRISPR/Cas9-engineered cell lines for target identification and target validation projects. A cell biologist by training, Ulrike received a PhD from the University of Oxford, United Kingdom in 2017 and holds a BSc and MSc degree in Biochemistry from Ludwig Maxim